Early Access — free while we kick the tires
EdgarHawk

Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
4 filings analyzed · 1 company · Latest 2026-02-04

Companies

Company Buys Sells Direction
Natera, Inc. NTRA 0 9 Net selling

Activity

February 2026
2026-02-04 Natera, Inc. NTRA
high
Sell
3,594 shares
$830,279
Significance 6/10

NTRA CFO/President Fesko sells 3,594 shares ($830.3K) in 2 transactions; stock down 19.2% from 52-week high, insider sold 90d-well-timed in all 3 measurable prior NTRA trades.

Fesko John, President and Chief Business Officer, executed two separate sales on 2026-02-03 totaling 3,594 shares for $830,278.57 at a blended average price of $231.02, reducing his holdings by 2.0% to 178,081 shares. The current price of $205.61 is 19.2% below the 52-week high and down 13.4% over 30 days, reflecting meaningful recent weakness. His timing pattern at NTRA is notable: his 3 prior measurable sells all delivered negative 90-day returns (ranging from -6.2% to -7.5%), indicating consistent execution before subsequent declines. The company remains unprofitable on a full-year basis despite strong revenue growth of +56.8%, and Natera's $28.4B market cap reflects investor expectations for profitability that have yet to materialize. This sale occurs amid significant momentum deterioration and follows a pattern of well-timed exits at this ticker.

January 2026
2026-01-22 Natera, Inc. NTRA
high
Sell
18,145 shares
$4,259,417
Significance 7/10

NTRA President John Fesko sells 18,145 shares for $4.3M; track record shows 100% well-timed sell rate at 90d.

John Fesko, President and Chief Business Officer, executed 2 separate sales totaling 18,145 shares for $4,259,416.95 on January 20–21, 2026, reducing his holdings by 9.3% from 195,397 to 177,252 shares. His cross-ticker track record across all open-market history shows a 100% well-timed rate at the 90-day mark (5 prior sells with avg 90d return of -9.8%), and his prior trades at NTRA specifically show 5 of 5 sells were well-timed, with 90-day post-sale declines ranging from -6.6% to -15.9%. The current stock price ($242.91) sits 4.5% below the 52-week high and has posted a +26.2% gain over 90 days, which provides the near-term context: Fesko executed this sale while the stock was elevated compared to its peak, consistent with the timing pattern observed in both his cross-ticker history and his NTRA-specific transactions.

January 2025
2025-01-31 Natera, Inc. NTRA
medium
Sell
4,030 shares
$668,454
Significance 6/10

Fesko sells 4,030 shares (2.7% of holdings) at avg $165.87; stock now at $176.92 amid 42.5% YTD rally

John Fesko, President and Chief Business Officer, executed three separate sales totaling 4,030 shares for $668,453.90 on 2025-01-29, reducing his holdings from 147,230 to 143,200 shares (2.7% reduction). The sales occurred at an average price of $165.87, while the stock now trades at $176.92—a gap of +$11.05 per share—after rising 42.5% over the past 90 days and reaching its 52-week high. Fesko has only 2 prior cross-ticker sells in his history, and his two recent same-ticker sales on 2025-01-22 remain unmeasurable in outcome. This sale follows a sharp rally in the company, which reported a $-31.6M net loss on revenue of $439.8M last quarter despite 32% annual growth, and now carries a $23.4B market cap.

2025-01-24 Natera, Inc. NTRA
medium
Sell
21,228 shares
$3,501,905
Significance 5/10

President/COO Fesko sold 21,228 shares at blended $164.97 for $3.5M, reducing holdings by 12.6%

Fesko John, President and Chief Business Officer, executed 2 separate sales totaling 21,228 shares for $3,501,904.81, reducing his holdings from 168,458 to 147,230 shares. The blended average transaction price was $164.97, slightly below the current price of $167.61. While Natera shows strong fundamentals—annual revenue growth of +32.0% and a 52-week high of $176.61—the company remains unprofitable with a net income of $-31,592,000 in the latest period. The 12.6% reduction in post-transaction holdings represents a material reduction but occurs against the backdrop of recent positive momentum (90-day stock price change of +42.4%), leaving the directional significance of the sale indeterminate without additional context on scheduling or prior trading patterns.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access